subject: Report from India to see huge potential in China pharmaceutical outsourcing market - pharmaceutical outsourcing - the pharmaceutical industries [print this page] Report from India to see huge potential in China pharmaceutical outsourcing market - pharmaceutical outsourcing - the pharmaceutical industries
India Medicine Organization of production in August released a report entitled "Rapid growth: the era of pharmaceutical outsourcing in India," the report stressed the global pharmaceutical outsourcing market opportunities brought to India and Indian outsourcing to be taken in the medical policies and measures. The report noted that India currently holds about 3% of the global outsourcing market, which means that in the global outsourcing business in India, there are enormous growth opportunities. However, because of India's intellectual property system, the global pharmaceutical and biotechnology industry does not take full advantage of India's pharmaceutical production and outsourcing capabilities. To change this situation, India is trying through the establishment of infrastructure, emphasis on quality culture in the traditional use of biological production, cell and freeze new technology to change the global pharmaceutical industry in India awareness.
Report, 2008, the global pharmaceutical market with the lowest growth rate in 10 years to achieve significant growth and is expected to slow this growth will continue. Reasons of slower growth in R & D and production capacity to lower development, the global economic crisis, increased competition and patent blockbuster drugs, miss. In this situation, outsourcing is a growing realization of medicine in a "strategic imperative." At present, the global pharmaceutical outsourcing business started to like India, China and other Asian emerging market shift.
The Indian pharmaceutical market growth rate of 43% growth rate is 3 times the global market. The report pointed out that the rapid growth of the Indian pharmaceutical market, mainly due to its lower production costs, abundant skilled workers and technical capacity. Support a survey of the report, India's attractiveness in living cost-effectiveness in emerging markets in Asia first in 6 countries. India in the API and formulation expertise is being developed highly valued. In addition, 2 / 3 of the respondents believe that India's rapid emergency response project management and attractive in terms of significantly higher than the global average.
Order to improve India's position in the pharmaceutical outsourcing market, the Indian government plans and has begun to take initial action, such as streamlining the production permit and export license approval process, with the U.S. FDA and EU EMEA and other organizations such as the establishment of a Memorandum of Understanding. Indian government also plans to invest in supporting infrastructure, such as the establishment of temperature control zones.
In addition, India is a global drug discovery and development services for the new hot spot. According to the report, India's drug discovery and R & D services market is to roughly 65% annual growth rate higher than the global growth rate of 2 to 3 times. Strong chemical research capabilities in India, plenty of skilled workers and good value for the ratio contributed to the rapid growth in this area.
The same time, India Pharmacy Industry "lack of innovation culture." R & D investment in India is far less than the U.S., Japan and Germany, knowledge and talent in the industrial sector and the transfer between the academic degree is low, and interdisciplinary Education Also hampered the lack of innovative pharmaceutical industry in India.
Is noteworthy that the Indian government has realized the importance of R & D and innovation, and began to take the following measures: strengthening public-private funding Cooperation ; Promotion of industry, academia and government cooperation; establishment of seven national medical training and research institutions; encourage enterprises dedicated to the discovery of new drugs and research. As a global pharmaceutical outsourcing
the land of another, our country in the world pharmaceutical outsourcing business in the scale of over 1.4 billion U.S. dollars, accounting for the world market of 2% to 3% less in India. However, China's industrial infrastructure is better in India, also has the advantage of low labor costs; In addition, target identification and validation in the field as well as genomics and proteomics-related fields, my superior.
The next few years, the growth rate of European and American markets is expected to decline, while growth in emerging markets in Asia is expected to reach 11% ~ 14%, which will bring the Asian countries, great development opportunities. As India's largest competitor, has begun to take measures to promote the development of pharmaceutical outsourcing market, and to the future of medicine as a medical increase outsourcing of "strategic imperative." China must act quickly, by forming strategic alliances to accelerate the infrastructure and supporting R & D bases, the establishment of trade associations and other measures, to integrate all aspects of technical superiority, build the core competitiveness.
